These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32700476)

  • 1. Effect of genetic variation in Notch regulator DTX1 on SCLC prognosis compared with the effect on NSCLC prongosis.
    Yoo SS; Lee JH; Hong MJ; Choi JE; Kang HG; Do SK; Kim JH; Baek SA; Choi SH; Lee WK; Lee YH; Seo H; Lee J; Lee SY; Cha SI; Kim CH; Park JY
    Thorac Cancer; 2020 Sep; 11(9):2698-2703. PubMed ID: 32700476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery.
    Lee JH; Shin KM; Lee SY; Hong MJ; Choi JE; Kang HG; Do SK; Lee WK; Lee EB; Seok Y; Jeong JY; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Kim YC; Oh IJ; Na KJ; Kim MS; Lee JM; Yang HC; Jung CY; Park CK; Lee MK; Kim DK; Park JY
    Ann Surg Oncol; 2019 Oct; 26(11):3756-3764. PubMed ID: 31313037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
    Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
    J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.
    Lin MW; Su KY; Su TJ; Chang CC; Lin JW; Lee YH; Yu SL; Chen JS; Hsieh MS
    Lung Cancer; 2018 Nov; 125():282-290. PubMed ID: 30429033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin expression impacts prognostically on NSCLC but not SCLC.
    Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A
    Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis.
    Udagawa H; Umemura S; Murakami I; Mimaki S; Makinoshima H; Ishii G; Miyoshi T; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuchihara K; Goto K
    Lung Cancer; 2018 Dec; 126():182-188. PubMed ID: 30527185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer.
    Bhateja P; Chiu M; Wildey G; Lipka MB; Fu P; Yang MCL; Ardeshir-Larijani F; Sharma N; Dowlati A
    Cancer Med; 2019 Apr; 8(4):1459-1466. PubMed ID: 30773851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KMT2D Mutation Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer.
    Ardeshir-Larijani F; Bhateja P; Lipka MB; Sharma N; Fu P; Dowlati A
    Clin Lung Cancer; 2018 Jul; 19(4):e489-e501. PubMed ID: 29627316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study.
    Xu Y; Wang Y; Liu H; Kang X; Li W; Wei Q
    Oncotarget; 2016 Sep; 7(38):61716-61727. PubMed ID: 27557513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients.
    Rijavec M; Silar M; Triller N; Kern I; Cegovnik U; Košnik M; Korošec P
    Pathol Oncol Res; 2011 Sep; 17(3):691-6. PubMed ID: 21455636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer.
    Zhou H; Hu Y; Luo R; Zhao Y; Pan H; Ji L; Zhou T; Zhang L; Long H; Fu J; Wen Z; Wang S; Wang X; Lin P; Yang H; Wang J; Song M; Yi X; Yang L; Xia X; Guan Y; Fang W; Yang Y; Hong S; Huang Y; Li P; Zhang Y; Zhou N
    Nat Commun; 2021 Sep; 12(1):5431. PubMed ID: 34521849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.
    Di Bernardo MC; Matakidou A; Eisen T; Houlston RS;
    Lung Cancer; 2009 Aug; 65(2):237-41. PubMed ID: 19117638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium.
    Shepshelovich D; Xu W; Lu L; Fares A; Yang P; Christiani D; Zhang J; Shiraishi K; Ryan BM; Chen C; Schwartz AG; Tardon A; Wu X; Schabath MB; Teare MD; Le Marchand L; Zhang ZF; Field JK; Brenner H; Diao N; Xie J; Kohno T; Harris CC; Wenzlaff AS; Fernandez-Tardon G; Ye Y; Taylor F; Wilkens LR; Davies M; Liu Y; Barnett MJ; Goodman GE; Morgenstern H; Holleczek B; Brown MC; Liu G; Hung RJ
    J Thorac Oncol; 2019 Sep; 14(9):1594-1607. PubMed ID: 31163278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific association of
    Hao Y; Lu R; Guo Y; Bao P
    Saudi Med J; 2024 Aug; 45(8):783-790. PubMed ID: 39074897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlations between genetic variations of glutathione synthetase gene and the response to platinum-based chemotherapy and prognosis of small cell lung cancer patients].
    Feng T; Li HM; Yuan P; Yu DK; Ma F; Tan WW; Du ZL; Yang J; Huang Y; Lin DX; Xu BH; Tan W
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):115-120. PubMed ID: 28219206
    [No Abstract]   [Full Text] [Related]  

  • 16. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
    Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B
    Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DDP-sensitivity-related genes in 10 lung cancer cell lines].
    Li CH; Cai L; Chen XS; Meng QW; Sui GJ
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):418-21. PubMed ID: 19024514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of new membrane-associated proteins overexpressed in small-cell lung cancer.
    Ocak S; Friedman DB; Chen H; Ausborn JA; Hassanein M; Detry B; Weynand B; Aboubakar F; Pilette C; Sibille Y; Massion PP
    J Thorac Oncol; 2014 Mar; 9(3):324-36. PubMed ID: 24518087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
    Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNFSF15 promoter polymorphisms increase the susceptibility to small cell lung cancer: a case-control study.
    Gao H; Niu Z; Zhang Z; Wu H; Xie Y; Yang Z; Li A; Jia Z; Zhang X
    BMC Med Genet; 2019 Feb; 20(1):29. PubMed ID: 30736740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.